ECTRIMS
B

Infection Risk Associated With New NMOSD Treatments: Anti-CD19 (Inebilizumab), Eculizumab and Satralizumab

By ECTRIMS FEATURING Brian Weinshenker
By ECTRIMS FEATURING Brian Weinshenker
0 views
September 30, 2021
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
08:13
Dominika Stastna

Effectiveness of Tixagevimab/Cilgavimab (Evusheld) in AntiCD20-Treat…

13:46
Cleveland Clinic Neurological Institute

Diagnostic Criteria for Myelin Oligodendrocyte Glycoprotein Antibody…

Feat. J. R. Abbatemarco
15:37
University of Miami

The Role of Optical Coherence Tomography in Neurology

Feat. H. Jiang
18:31
University of Miami

Optical Coherence Tomography (OCT) in Neuromyelitis Optica Spectrum …

Feat. H. Jiang
28:41
University of Miami

Management of Neuromyelitis Optica Spectrum Disorders (NMOSD) in 2022

Feat. L. Tornes
15:17
University of Miami

Anti-C5 Complement Therapy in NMO: Eculizumab and Ravulizumab

Feat. F. Nelson
30:05
2023 Conference Coverage

Neuroimaging Case Studies in Inflammation and Demyelination

Feat. U. Kaunzner
18:18
University of Miami

IL6 Receptor Inhibition in Treatment of NMOSD

Feat. K. Rammohan
13:50
Bruce Cree

Neuromyelitis Optica: Acute and Preventative Treatments in the Era o…

10:35
Justin R. Abbatemarco

Update in Autoimmune Neurology & Neuroimmunology

32:34
University of Miami

Everything a Neurologist Needs to Know About NMO & MOG

Feat. M. Levy
10:25
Giulia Fadda

Imaging Features of MOGAD and Key Flags

48:54
Olga Rosenvald Thon

The Current Spectrum of NMOSD

21:07
University of Miami

MOG Antibody Disease (MOGAD) Update

Feat. M. Ortega
34:59
McMaster University Department of Medicine

Challenges of Neurological Presentations in Rheumatic Diseases: Lab …

Feat. E. Shosha
31:43
Cedars Sinai

Diagnostic Criteria and Biomarkers on the Horizon (MRI, OCT, Blood)

Feat. O. Al-Louzi
33:02
University of Miami

NMO and MOG Case Presentations

Feat. H. Jiang, M. Levy, F. Nelson, K. Rammohan, M. Ortega
22:34
University of Miami

COVID-19 Infection in Multiple Sclerosis and Neuromyelitis Optica Sp…

Feat. C. Dixon
04:55
2023 Conference Coverage

Safety and Efficacy of Inebilizumab in AQP4+ NMOSD Participants with…

Feat. F. Paul
54:13
ZINCARE

Neuromyelitis Optica Spectrum Disorder (NMOSD), MOG-IgG Associated D…

Feat. E. Sotirchos